| Sunan alama | ActiTid™ e-AH3 (Liquefied 500) |
| Lambar CAS | 7732-18-5; 616204-22-9; 1117-86-8 |
| Sunan INCI | Ruwa; Acetyl hexapeptide-8; Capryl glycol |
| Aikace-aikace | Man shafawa, Magani, Abin Rufe Fuska, Mai Tsaftace Fuska |
| Kunshin | 1kg/kwalba |
| Bayyanar | Ruwa mai haske da haske |
| Abubuwan da ke cikin peptide | 0.045 – 0.060% |
| Narkewa | Ruwa mai narkewa |
| aiki | Jerin Peptide |
| Tsawon lokacin shiryayye | Shekaru 2 |
| Ajiya | A adana a wuri mai sanyi da bushewa, nesa da haske. 2~8°C don ajiya |
| Yawan amfani | 3.0-10.0% |
Aikace-aikace
Bincike kan muhimman hanyoyin hana wrinkles ya haifar da gano ActiTide™ AH3, wani sabon nau'in hexapeptide da aka haɓaka ta hanyar tsarin kimiyya daga ƙira mai ma'ana zuwa samar da GMP, tare da sakamako mai kyau.
ActiTide™ AH3 yana ba da ingantaccen rage wrinkles kamar Botulinum Toxin Type A, yayin da yake guje wa haɗarin allurar kuma yana ba da ingantaccen farashi mai kyau.
Fa'idodin Kayan Kwalliya:
ActiTide™ AH3 yana rage zurfin wrinkles wanda tsokoki na fuska ke haifarwa, tare da tasirin gaske akan wrinkles na goshi da periocular.
Tsarin Aiki:
Matsewar tsoka tana faruwa ne bayan an saki neurotransmitter daga vesicles na synaptic. Haɗaɗɗen SNARE - haɗuwa ta ternary na sunadaran VAMP, Syntaxin, da SNAP-25 - yana da mahimmanci don toshewar vesicle da exocytosis na neurotransmitter (A. Ferrer Montiel et al., JBC 1997, 272:2634-2638). Wannan hadadden yana aiki azaman ƙugiya ta sel, yana kama vesicles da haɗa membrane.
A matsayin wani tsari na SNAP-25 N-terminus, ActiTide™ AH3 tana fafatawa da SNAP-25 don haɗawa cikin hadaddun SNARE, tana daidaita haɗuwarta. Rashin daidaituwar hadaddun SNARE yana lalata toshewar vesicle da sakin neurotransmitter daga baya, wanda ke haifar da raguwar matsewar tsoka da hana wrinkles da samuwar layi mai laushi.
ActiTide™ AH3 madadin Botulinum Toxin Type A ne mafi aminci, araha, kuma mafi laushi. Yana kai hari ga hanyar da ke haifar da wrinkles a jiki amma yana aiki ta wata hanya daban.
